Clinical Trials Logo

Uterine Fibroid clinical trials

View clinical trials related to Uterine Fibroid.

Filter by:

NCT ID: NCT06430320 Enrolling by invitation - Uterine Fibroid Clinical Trials

Ascertaining Longterm Outcomes of Fibroid Treatments

ALOFT
Start date: May 20, 2024
Phase:
Study type: Observational

The goal of the ALOFT study is to understand the health of women in the 12 years following a uterine fibroid (UF) treatment. ALOFT is a multi-center, prospective, observational cohort study of approximately 700 women who have undergone uterine-sparing treatment procedures for UF and previously participated in the longitudinal studies COMPARE-UF (NCT02260752) or ULTRA (NCT02100904). The primary uterine sparing treatment procedures undergone by study participants are myomectomy, endometrial ablation (EA), uterine artery embolization (UAE) and laparoscopic radiofrequency ablation (RFA). A smaller number of women may be studied who underwent focused ultrasound, intrauterine device (IUD), and medical management. Two follow-up study contacts with COMPARE-UF and ULTRA participants will occur to assess changes in UF symptoms and treatment failure which is defined as the need for another UF treatment procedure. Questionnaires will be used to collect data on patient-reported characteristics and outcomes and quality of life. The study's analyses will focus on comparisons of primary and secondary outcomes among women.

NCT ID: NCT06244251 Active, not recruiting - Uterine Fibroid Clinical Trials

Comparison Between Laparoendoscopic Single-site Surgery and Multi-port Laparoscopy in Treating Uterine Fibroids

Start date: June 24, 2023
Phase: N/A
Study type: Interventional

Myomectomy was preferably applied in females with reproductive requirements, which could be achieved by transumbilical laparoendoscopic single-site surgery (TU-LESS) or multi-port laparoscopic surgery (MPLS). Power morcellation used in MPLS was correlated with unidentified risk of tumor dissemination, especially in cases with accidental surgical findings of uterine sarcoma or leiomyosarcoma. Moreover, TU-LESS was reported to exceed MPLS in fast recovery. Therefore, the aim of this prospective cohort study is to compare the effectiveness of fast recovery and relative risk of tumor dissemination between TU-LESS and MPLS in myomectomy for the treatment of uterine fibroids.

NCT ID: NCT06234670 Not yet recruiting - Recurrence Clinical Trials

Risk Factors and A Prediction Model of Recurrence of Uterine Fibroids

Start date: January 25, 2024
Phase:
Study type: Observational

To research risk factors for recurrence of uterine fibroids and build a prediction model of recurrence of uterine fibroids to facilitate the early detection as well as the early intervention for patients who are prone to recur.

NCT ID: NCT06153667 Not yet recruiting - Uterine Fibroid Clinical Trials

Bearing nsPVA Embolization for Uterine Artery Embolization (BETTER-UAE)

BETTER-UAE
Start date: June 2024
Phase:
Study type: Observational

This is a prospective, multicenter, observational, post-market clinical follow-up study in subjects treated with Bearing nsPVA Embolization Particles for uterine fibroid embolization. Data collection will include safety and performance outcome relating to the use of Bearing nsPVA, through 6 months.

NCT ID: NCT06106633 Recruiting - Uterine Fibroid Clinical Trials

Pain Reduction and Ovarian Perfusion Following Uterine Fibroid Embolization

PEDD-UFE
Start date: February 9, 2023
Phase: N/A
Study type: Interventional

The goal of this study is to assess of Pressure-Enabled Drug Delivery on fibroid treatment in patients undergoing UFE.

NCT ID: NCT06020924 Recruiting - Female Infertility Clinical Trials

The Effects of Uterine Fibroids on Pregnancy in Women

Start date: August 31, 2023
Phase:
Study type: Observational

Female fertility may be affected by uterine fibroids, although this association has not been elucidated. This retrospective cohort study aims to evaluate the impact of fibroids on women fertility.

NCT ID: NCT06009562 Recruiting - Pregnancy Related Clinical Trials

Management of Symptomatic Uterine Fibroids in Pregnancy by Laparotomic Myomectomy: a Prospective Cohort Study

LPTM-UFs-P
Start date: August 19, 2023
Phase:
Study type: Observational [Patient Registry]

The frequency of women presenting with a combination of uterine fibroids and pregnancy is in-creasing nowadays. Uterine fibroids in pregnancy are an unfavorable condition in themselves and being reactive to hormonal stimuli, tending to grow, can generate symptoms of different lev-els of severity. Obstetrics and gynecologists are increasingly faced with the problem of clarifying the management tactics of pregnant patients with symptomatic fibroids, who may see their preg-nancy put at risk by these masses.

NCT ID: NCT05986266 Completed - Uterine Fibroid Clinical Trials

Evaluating Efficacy of Intravenous Carbetocin Versus Intramyometrial Injection of Adrenaline in Reducing Blood Loss

Start date: February 1, 2023
Phase: Phase 1
Study type: Interventional

Uterine fibroids, affecting 20-50% of all women ,and are benign tumors that arise from myometrial cells of the uterine smooth muscle tissue. Although most are asymptomatic, fibroids can often cause abnormal uterine bleeding, iron deficiency anemia, pelvic pressure symptoms and pain

NCT ID: NCT05840042 Not yet recruiting - Uterine Fibroid Clinical Trials

Epidemiology and Risk Factors of Uterine Fibroids in China

Start date: June 19, 2023
Phase:
Study type: Observational

Uterine fibroids are the most common form of benign uterine tumors in the uterine muscle layer, which had a certain rate of malignancy, but it is rare. The prevalence of uterine fibroids estimates range from 4.5% to 68.6% depending on study population and diagnostic methodology. The prevalence of fibroids has been historically underestimated by epidemiologic studies which focused mainly on symptomatic women, leaving behind a large population of asymptomatic women and women who underreport their symptoms. What investigators don't know was which women who have fibroids will develop clinical symptoms and which women who have an operation of myomectomy will relapse. The purpose of this study is to investigate the prevalence, incidence and risk factors for the development of uterine fibroids in Chinese women.

NCT ID: NCT05695690 Not yet recruiting - Uterine Fibroid Clinical Trials

Role of US in Uterine Fibroids in Comparison With MRI Using FIGO Classification

Start date: May 2023
Phase:
Study type: Observational

Evaluation of diagnostic accuracy of ultrasound in uterine fibroid characterization compared with MRI using FIGO classification